Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 110.02 billion as of August 14, 2025. Its market cap has increased by 11.97% in one year.

Market Cap

110.02B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

65.88

Stock Price

3,870.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 110.02B, an increase of 282.34%. That is a compound annual growth rate of 4.58%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	110.02B	10.88%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	212.94B	47.61%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.67T
Celltrion	38.01T
ALTEOGEN	24.00T
Yuhan	8,309.02B
Peptron	8,130.78B
SK Biopharmaceuticals	7,846.99B
PharmaResearch	6,950.67B
LigaChem Biosciences	5,648.08B

Market Cap Rankings